Vimarsana
Biggest News Aggregation in the World

Page 7 - Newborn Screening Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Newborn Screening Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Newborn Screening Program Today - Breaking & Trending Today

Minnesota begins newborn screenings for a common cause of birth defects - Vimarsana News

Minnesota begins newborn screenings for a common cause of birth defects

Minnesota officials announced the state will be the first in the nation screening all newborns for cytomegalovirus.

Source: usf.edu
Via Christi Newborn Screening Program receives recognition - Vimarsana News

Via Christi Newborn Screening Program receives recognition

Ascension Via Christi Hospital in Pittsburg announced this week that it has been recognized for its Newborn Screening Program, a service done 24 to 48 hours after birth to identify and treat rare conditions.  

Meharry Sickle Cell Center celebrates 50 years of service to sickle cell disease community - Vimarsana News

Meharry Sickle Cell Center celebrates 50 years of service to sickle cell disease community

For 50 years, the Meharry Sickle Cell Center (MSCC) has diagnosed individuals with hemoglobinopathies and connected them to treatment—working in conjunction with the Tennessee Department of Health (TDOH), which performs universal newborn screening for treatable inherited conditions not clinically evident in the newborns, including sickle cell disease.

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease - Vimarsana News

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease

/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease - Vimarsana News

Sentynl Therapeutics Recognizes Menkes Disease Awareness Month, Committed to the Development of Tests for Early Diagnosis of Patients with Menkes Disease

/PRNewswire/ -- Sentynl Therapeutics, Inc. ("Sentynl") a US-based biopharmaceutical company focused on bringing innovative therapies to patients living with...